Showing 81 - 100 of 131 results
By submitting a proposal for Merit Access to ANSTO’s Biosciences, Centre for Accelerator Science, Isotope Tracing, Nuclear Stewardship or the Vivarium capabilities, you are agreeing to the following Terms and Conditions. These Terms and Conditions apply to external merit researchers, scientific collaborators and partners unless there is a specific agreement in place between ANSTO and the home institution of the Principal Investigator.
Both the Australian Centre for Neutron Scattering and the National Deuteration Facility share in grants
Second half of 2018
Scientific merit of applications for beamtime assessed.
Monash University researchers have used advanced techniques at ANSTO to investigate the production of new, elongated polymer nanocapsules with a high payload of drug nanocrystals to potentially increase drug targetability, and also decrease dosage frequency and side effects.
Government response to 2016 National Research Infrastructure Roadmap
A selection of research highlights, instrument news and technical developments for scientists.
ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week. Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.
University of Melbourne researchers have investigated a method to produce magnetic nanoparticles in Australia for use in COVID-19 PCR tests.
Robert Russell has been awarded his PhD
ANSTO leverages great science to deliver big outcomes. We partner with scientists and engineers and apply new technologies to provide real-world benefits. Our work improves human health, saves lives, builds our industries and protects the environment.